Papers
14
Total Citations
267
H-Index
7
About
Dr. Emanuele Perrone is a pioneering gynecologic surgeon whose research focuses on the evolution of minimally invasive surgery, particularly robotic-assisted systems, for the treatment of gynecologic malignancies and complex benign conditions. His major contributions center on evaluating the safety, efficacy, and oncologic outcomes of novel robotic platforms, such as the Senhance™ and TELELAP ALF-X systems, in procedures ranging from total hysterectomy in obese patients to endometrial cancer staging. Notably, his pilot study on Senhance™ robotic hysterectomy in obese patients has garnered 75 citations, while his large retrospective study comparing laparoscopic and robotic-assisted laparoscopy in endometrial cancer staging (34 citations) involved over 1,200 patients, providing robust evidence for the field. Dr. Perrone has also led prospective randomized trials, including the ROMANHY trial (28 citations), which investigates the role of uterine manipulators on lymphovascular space invasion in early-stage endometrial cancer, and the ongoing RObese study (16 citations), addressing robotic surgery in obese patients. His work extends to innovative techniques like robotic video endoscopic inguinal lymphadenectomy for vulvar cancer, demonstrating his commitment to advancing surgical precision and patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 33 mm Senhance robotic hysterectomy: a step towards future perspectives38 citations · 2018
- 4
- 5
- 6
- 7
- 8Reply5 citations · 2017
- 9
- 10